Alliance to buy Cambridge Laboratories
Health / Medicine Related News
The speciality drug company is to buy the bulk of Cambridge Laboratories in a deal valued at between £14m and £16m that will be part-funded with a share placing by Alliance
Source: FT.com - Pharmaceuticals